Journal of Vascular Surgery
Volume 45, Issue 6 , Pages 1109-1113 , June 2007

Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm

  • Anders Wanhainen, MD, PhD

      Affiliations

    • Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden
    • Corresponding Author InformationCorrespondence: Dr Anders Wanhainen, Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, SE-371 85 Uppsala, Sweden.
    • ,
  • Torbjörn K. Nilsson, MD, PhD

      Affiliations

    • Department of Clinical Chemistry, Örebro University Hospital, Uppsala, Sweden
    • ,
  • David Bergqvist, MD, PhD

      Affiliations

    • Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden
    • ,
  • Kurt Boman, MD, PhD

      Affiliations

    • Department of Medicine, Skellefteå County Hospital, Uppsala, Sweden
    • Institution of Public Health and Clinical Medicine, Umeå University Hospital, Uppsala, Sweden.
    • ,
  • Martin Björck, MD, PhD

      Affiliations

    • Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden

Received 25 September 2006 ,Accepted 4 February 2007.

References 

  1. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–1589
  2. Sakalihasan N, Delvenne P, Nusqens BV, Limet R, Lapiere CM. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg. 1996;24:127–133
  3. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci. 1996;800:157–174
  4. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998;102:1900–1910
  5. Jovin IS, Muller-Berghaus G. Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis. Atherosclerosis. 2004;174:225–233
  6. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci. 1992;667:1–12
  7. Werb J, Bainton DF, Jones PA. Degradation of connective tissue matrices by macrophages. J Exp Med. 1989;152:1340–1356
  8. Nagase H, Enghild JJ, Suzuki K, Salvesen G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry. 1990;29:5783–5789
  9. Jean-Claude J, Newman KM, Li H, Gregory AK, Tilson MD. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery. 1994;116:472–478
  10. Lindholt JS, Jorgensen B, Fasting H, Henneberg EW. Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysm expanding to operation-recommendable size. J Vasc Surg. 2001;34:611–615
  11. Collen D, Lijnen HR. Tissue-type plasminogen activator: a historical perspective and personal account. J Thromb Haemost. 2004;2:541–546
  12. Mayor M. Biochemical and biological aspects of the plasminogen activation system. Chlin Biochem. 1990;23:197–211
  13. Smith FB, Lee AJ, Rumley A, Fowkes FGR, Lowe GDO. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis. 1995;115:35–43
  14. Wanhainen A, Bjorck M, Boman K, Rutegard J, Bergqvist D. Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm. J Vasc Surg. 2001;34:229–235
  15. Wanhainen A, Bergqvist D, Boman K, Nilsson TK, Rutegard J, Bjorck M. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg. 2005;41:390–396
  16. Protokoll från förvaltningsutskottets sammanträde 1984-12-17. [Protocol from the County council board meeting, Dec 17, 1984]. Umeå: Västerbottens Läns Landsting. §470.
  17. Reilly JM, Sicard GA, Lucore CL. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg. 1994;19:865–872
  18. Shireman PK, McCarty WJ, Pearce WH, Shively VP, Cipollone M, Kwaan HC. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseases aorta. J Vasc Surg. 1997;25:157–164
  19. Tromholt N, Jorgensen SJ, Hesse B, Hansen MS. In vivo demonstration of focal fibrinolytic activity in abdominal aortic aneurysms. Eur J Vasc Surg. 1993;7:675–679
  20. Schneiderman J, Bordin GM, Engelberg I, Adar R, Seiffert D, Thinnes T, et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall (A possible mechanism for aneurysm expansion). J Clin Invest. 1995;96:639–645
  21. Louwrens HD, Kwaan HC, Pearce WH, Yao JS, Verrusio E. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture. Eur J Vasc Endovasc Surg. 1995;10:289–293
  22. Fontaine V, Jacob MP, Houard X, Rossignol P, Plissonnier D, Angles-Cano E, et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol. 2002;161:1701–1710
  23. Lindholt JS, Jorgensen B, Shi GP, Henneberg EW. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2003;25:546–551
  24. Shireman PK, McCarthy WJ, Pearce WH, Shively VP, Cipollone M, Kwaan HC, et al. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta. J Vasc Surg. 1996;23:810–817
  25. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA. 1992;89:6998–7002
  26. Defawe OD, Colige A, Lambert CA, Munaut C, Delvenne P, Lapiere CM, et al. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Res. 2003;60:205–213
  27. Seeman-Lodding H, Haggmark S, Jern C, Jern S, Johansson G, Winso O, et al. Systemic levels and preportal organ release of tissue-type plasminogen activator are enhanced by PEEP in the pig. Acta Anaesthesiol Scand. 1999;43:623–633
  28. Rumley A, Emberson JR, Wannamethee SG, Lennon L, Whincup PH, Lowe GD. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years. J Thromb Haemost. 2006;4:982–987

 Competition of interest: none.

PII: S0741-5214(07)00252-2

doi: 10.1016/j.jvs.2007.02.001

Journal of Vascular Surgery
Volume 45, Issue 6 , Pages 1109-1113 , June 2007

Article Tools

* Image Usage & Resolution